These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30355786)

  • 1. Estrogen Signaling in Bystander Foxp3
    Garnier L; Laffont S; Lélu K; Yogev N; Waisman A; Guéry JC
    J Immunol; 2018 Dec; 201(11):3218-3228. PubMed ID: 30355786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor α signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis.
    Lélu K; Laffont S; Delpy L; Paulet PE; Périnat T; Tschanz SA; Pelletier L; Engelhardt B; Guéry JC
    J Immunol; 2011 Sep; 187(5):2386-93. PubMed ID: 21810607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1.
    Hirahara K; Ghoreschi K; Yang XP; Takahashi H; Laurence A; Vahedi G; Sciumè G; Hall AO; Dupont CD; Francisco LM; Chen Q; Tanaka M; Kanno Y; Sun HW; Sharpe AH; Hunter CA; O'Shea JJ
    Immunity; 2012 Jun; 36(6):1017-30. PubMed ID: 22726954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway.
    Herold M; Posevitz V; Chudyka D; Hucke S; Groß C; Kurth F; Leder C; Loser K; Kurts C; Knolle P; Klotz L; Wiendl H
    J Immunol; 2015 Oct; 195(8):3584-95. PubMed ID: 26378076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis.
    Liu JQ; Liu Z; Zhang X; Shi Y; Talebian F; Carl JW; Yu C; Shi FD; Whitacre CC; Trgovcich J; Bai XF
    J Immunol; 2012 Apr; 188(7):3099-106. PubMed ID: 22387555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
    Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
    Front Immunol; 2018; 9():3119. PubMed ID: 30687323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα.
    Nuro-Gyina PK; Rieser EL; Granitto MC; Pei W; Liu Y; Lee PW; Aqel S; Zhang J; Lovett-Racke AE; Racke MK; Yang Y
    J Neuroinflammation; 2016 Dec; 13(1):302. PubMed ID: 27912762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic role of interferon-γ in experimental autoimmune encephalomyelitis is mediated through a tolerogenic subset of splenic CD11b
    Arellano G; Acuña E; Loda E; Moore L; Tichauer JE; Castillo C; Vergara F; Burgos PI; Penaloza-MacMaster P; Miller SD; Naves R
    J Neuroinflammation; 2024 May; 21(1):144. PubMed ID: 38822334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D and estrogen synergy in Vdr-expressing CD4(+) T cells is essential to induce Helios(+)FoxP3(+) T cells and prevent autoimmune demyelinating disease.
    Spanier JA; Nashold FE; Mayne CG; Nelson CD; Hayes CE
    J Neuroimmunol; 2015 Sep; 286():48-58. PubMed ID: 26298324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-146a modulates autoreactive Th17 cell differentiation and regulates organ-specific autoimmunity.
    Li B; Wang X; Choi IY; Wang YC; Liu S; Pham AT; Moon H; Smith DJ; Rao DS; Boldin MP; Yang L
    J Clin Invest; 2017 Oct; 127(10):3702-3716. PubMed ID: 28872459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
    Aggelakopoulou M; Kourepini E; Paschalidis N; Panoutsakopoulou V
    J Immunol; 2016 Jun; 196(12):4947-56. PubMed ID: 27183630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
    Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
    J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR7 on CD4
    Belikan P; Bühler U; Wolf C; Pramanik GK; Gollan R; Zipp F; Siffrin V
    J Immunol; 2018 Apr; 200(8):2554-2562. PubMed ID: 29549177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of RORγt
    Kim BS; Lu H; Ichiyama K; Chen X; Zhang YB; Mistry NA; Tanaka K; Lee YH; Nurieva R; Zhang L; Yang X; Chung Y; Jin W; Chang SH; Dong C
    Cell Rep; 2017 Oct; 21(1):195-207. PubMed ID: 28978473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestrogen treatment of experimental autoimmune encephalomyelitis requires 17β-oestradiol-receptor-positive B cells that up-regulate PD-1 on CD4+ Foxp3+ regulatory T cells.
    Bodhankar S; Vandenbark AA; Offner H
    Immunology; 2012 Dec; 137(4):282-93. PubMed ID: 23039230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction.
    Lupar E; Brack M; Garnier L; Laffont S; Rauch KS; Schachtrup K; Arnold SJ; Guéry JC; Izcue A
    J Immunol; 2015 Nov; 195(10):4742-52. PubMed ID: 26453746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B cells.
    Bodhankar S; Wang C; Vandenbark AA; Offner H
    Eur J Immunol; 2011 Apr; 41(4):1165-75. PubMed ID: 21413005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD30 ligand is a new therapeutic target for central nervous system autoimmunity.
    Shinoda K; Sun X; Oyamada A; Yamada H; Muta H; Podack ER; Kira J; Yoshikai Y
    J Autoimmun; 2015 Feb; 57():14-23. PubMed ID: 25533628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells.
    Rouse M; Singh NP; Nagarkatti PS; Nagarkatti M
    Br J Pharmacol; 2013 Jul; 169(6):1305-21. PubMed ID: 23586923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1).
    Polanczyk MJ; Hopke C; Vandenbark AA; Offner H
    Int Immunol; 2007 Mar; 19(3):337-43. PubMed ID: 17267414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.